US reports first result of clinical trial of Covid-19 vaccine

Rate this item
(0 votes)

United States biotech firm, Moderna has reported promising early results from the first clinical tests of an experimental vaccine against the novel coronavirus performed on a small number of volunteers.

The Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in 8 people who received it similar to that seen in people recovering from the virus.



Moderna’s Chief Medical Officer,  Tal Zaks said the data substantiate their belief that mRNA-1273 has the potential to prevent COVID-19 disease and advance the company’s ability to select a dose for pivotal trials.


Moderna, which was founded nine years ago, said the vaccine was generally safe and well-tolerated and that patients suffered no more than redness or soreness from the shots.


A dozen clinical trials are taking place around the world with half of them in China, according to the London School of Hygiene and Tropical Medicine.

Read 88 times

Leave a comment

Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.

Subscribe to Newsletter

Recent Twitter Posts